These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 33903130)

  • 21. Children's hospital celebrates successful COVID-19 vaccine rollout.
    Traynor K
    Am J Health Syst Pharm; 2021 May; 78(10):838-839. PubMed ID: 33954418
    [No Abstract]   [Full Text] [Related]  

  • 22. [Vaccine does make sense, until used].
    Kobayashi TH
    Yakugaku Zasshi; 2011; 131(12):1743-4. PubMed ID: 22129868
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacy leadership, expertise imperative for successful COVID-19 vaccine rollout.
    Gregory N
    Am J Health Syst Pharm; 2021 Jul; 78(14):1264-1266. PubMed ID: 33955454
    [No Abstract]   [Full Text] [Related]  

  • 24. Ceftobiprole Medocaril: BAL5788, JNJ 30982081, JNJ30982081, RO 65-5788, RO 655788.
    Drugs R D; 2006; 7(5):305-11. PubMed ID: 16922591
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reflections On Governance, Communication, And Equity: Challenges And Opportunities In COVID-19 Vaccination.
    Salmon D; Opel DJ; Dudley MZ; Brewer J; Breiman R
    Health Aff (Millwood); 2021 Mar; 40(3):419-425. PubMed ID: 33539178
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Covid-19: Why the Balkans' vaccine rollout lags behind most of Europe.
    Boytchev H
    BMJ; 2021 Oct; 375():n2412. PubMed ID: 34610944
    [No Abstract]   [Full Text] [Related]  

  • 27. Cultural competence in vaccine rollout: migrants would face difficulties accessing covid-19 vaccines.
    Waterman LZ
    BMJ; 2021 Jan; 372():n220. PubMed ID: 33500270
    [No Abstract]   [Full Text] [Related]  

  • 28. Allergic Reactions to Current Available COVID-19 Vaccinations: Pathophysiology, Causality, and Therapeutic Considerations.
    Kounis NG; Koniari I; de Gregorio C; Velissaris D; Petalas K; Brinia A; Assimakopoulos SF; Gogos C; Kouni SN; Kounis GN; Calogiuri G; Hung MY
    Vaccines (Basel); 2021 Mar; 9(3):. PubMed ID: 33807579
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Factors Associated With US Adults' Likelihood of Accepting COVID-19 Vaccination.
    Kreps S; Prasad S; Brownstein JS; Hswen Y; Garibaldi BT; Zhang B; Kriner DL
    JAMA Netw Open; 2020 Oct; 3(10):e2025594. PubMed ID: 33079199
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of reporting of Stevens-Johnson syndrome and toxic epidermal necrolysis in association with selective COX-2 inhibitors.
    La Grenade L; Lee L; Weaver J; Bonnel R; Karwoski C; Governale L; Brinker A
    Drug Saf; 2005; 28(10):917-24. PubMed ID: 16180941
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Converting the maybes: Crucial for a successful COVID-19 vaccination strategy.
    Attwell K; Lake J; Sneddon J; Gerrans P; Blyth C; Lee J
    PLoS One; 2021; 16(1):e0245907. PubMed ID: 33471821
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of RNA secondary structure on the kinetics of DNA synthesis catalyzed by HIV-1 reverse transcriptase.
    Suo Z; Johnson KA
    Biochemistry; 1997 Oct; 36(41):12459-67. PubMed ID: 9376350
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An Evidence-Based Strategy to Scale Vaccination in Canada.
    Snowdon AW; Wright A; Saunders M
    Healthc Q; 2021 Apr; 24(1):28-35. PubMed ID: 33864438
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Actionable lessons for the US COVID vaccine program.
    Freed GL
    Isr J Health Policy Res; 2021 Feb; 10(1):14. PubMed ID: 33608052
    [TBL] [Abstract][Full Text] [Related]  

  • 35. COVID-19 Vaccine Failure in a Patient with Multiple Sclerosis on Ocrelizumab.
    Chilimuri S; Mantri N; Gongati S; Zahid M; Sun H
    Vaccines (Basel); 2021 Mar; 9(3):. PubMed ID: 33806646
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trabectedin: Ecteinascidin 743, Ecteinascidin-743, ET 743, ET-743, NSC 684766.
    Drugs R D; 2006; 7(5):317-28. PubMed ID: 16922593
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The race to a COVID-19 vaccine: opportunities and challenges in development and distribution.
    Burgos RM; Badowski ME; Drwiega E; Ghassemi S; Griffith N; Herald F; Johnson M; Smith RO; Michienzi SM
    Drugs Context; 2021; 10():. PubMed ID: 33643421
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recent experience in health promotion at Johnson & Johnson: lower health spending, strong return on investment.
    Henke RM; Goetzel RZ; McHugh J; Isaac F
    Health Aff (Millwood); 2011 Mar; 30(3):490-9. PubMed ID: 21383368
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stevens-Johnson Syndrome After Influenza Vaccine Injection.
    Oda T; Sawada Y; Okada E; Yamaguchi T; Ohmori S; Haruyama S; Yoshioka M; Nakamura M
    J Investig Allergol Clin Immunol; 2017; 27(4):274-275. PubMed ID: 28731419
    [No Abstract]   [Full Text] [Related]  

  • 40. Two False Negative Test Results in a Symptomatic Patient with a Confirmed Case of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) and Suspected Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis (SJS/TEN).
    Lagziel T; Quiroga L; Ramos M; Hultman CS; Asif M
    Cureus; 2020 May; 12(5):e8198. PubMed ID: 32455090
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.